BioRem Financials

BRM Stock  CAD 3.00  0.02  0.67%   
Please use analysis of BioRem Inc fundamentals to determine if markets are correctly pricing the company. We were able to interpolate thirty-two available fundamental indicators for BioRem Inc, which can be compared to its peers. The stock experiences a moderate upward volatility. Check odds of BioRem to be traded at C$3.3 in 90 days. Key indicators impacting BioRem's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio1.411.4829
Notably Down
Slightly volatile
  
Understanding current and past BioRem Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioRem's financial statements are interrelated, with each one affecting the others. For example, an increase in BioRem's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in BioRem's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioRem Inc. Check BioRem's Beneish M Score to see the likelihood of BioRem's management manipulating its earnings.

BioRem Stock Summary

BioRem competes with Thermal Energy, BluMetric Environmental, Vitreous Glass, and CHAR Technologies. BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds , and hazardous air pollutants in Canada, the United States, China, and internationally. In addition, it offers biological processes and testing services media sampling and analysis system review and inspections and media replacements and spare parts. BIOREM INC operates under Pollution Treatment Controls classification in Canada and is traded on TSX Venture Exchange.
Foreign Associate
  USA
Specialization
Industrials, Pollution & Treatment Controls
InstrumentCanada Stock View All
ExchangeTSX Venture Exchange
ISINCA09068G1046
Business Address7496 Wellington Road
SectorMachinery
IndustryIndustrials
BenchmarkDow Jones Industrial
Websitewww.biorem.biz
Phone519 767 9100
CurrencyCAD - Canadian Dollar
You should never invest in BioRem without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioRem Stock, because this is throwing your money away. Analyzing the key information contained in BioRem's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

BioRem Key Financial Ratios

There are many critical financial ratios that BioRem's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioRem Inc reports annually and quarterly.

BioRem Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets17.6M22.0M19.2M20.7M24.1M15.1M
Other Current Liab1.9M3.3M3.4M4.2M2.7M2.0M
Net Debt(6.4M)(8.0M)1.2M971.1K1.9M2.0M
Retained Earnings(9.1M)(7.0M)(5.7M)(4.1M)(1.9M)(2.0M)
Cash6.5M8.9M4.5M3.8M2.3M3.1M
Net Receivables5.7M7.6M10.1M12.2M15.1M7.8M
Inventory1.3M944.8K901.7K888.0K901.1K764.8K
Other Current Assets1.0M857.3K658.9K870.6K2.3M2.4M
Total Liab5.9M8.4M17.2M16.2M17.4M9.0M
Total Current Assets14.5M18.3M16.2M17.8M20.6M12.4M
Accounts Payable2.4M1.8M5.1M4.7M6.1M3.4M
Net Tangible Assets12.9M11.7M13.5M2.0M2.3M2.1M
Net Invested Capital11.7M13.5M7.0M8.8M9.7M8.1M
Net Working Capital8.6M10.5M2.9M4.9M6.7M5.8M

BioRem Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue20.6M24.4M24.5M28.9M25.2M18.5M
Gross Profit4.9M7.0M6.2M8.8M6.9M5.5M
Operating Income(1.0M)2.7M2.1M2.6M3.1M3.2M
Ebit(1.3M)2.6M2.3M2.9M3.1M3.2M
Research Development46.5K30.5K14.2K97.1K30.4K28.9K
Ebitda(1.1M)2.9M2.7M3.2M3.5M3.6M
Cost Of Revenue15.8M17.4M18.2M20.1M18.2M13.6M
Income Before Tax(1.0M)2.7M2.0M2.4M2.8M2.9M
Net Income(1.3M)2.1M1.3M1.6M2.2M2.3M
Income Tax Expense276.4K586.2K737.0K770.4K609.7K640.2K
Interest Expense3.3K43.7K35.9K257.2K273.4K202.3K
Net Interest Income(3.3K)(43.7K)(35.9K)(257.2K)(273.4K)(259.8K)
Tax Provision276.4K586.2K737.0K770.4K609.7K640.2K

BioRem Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash2.5M2.4M(4.4M)(696.3K)(1.5M)(1.4M)
Free Cash Flow2.4M3.0M3.7M1.2M(62.8K)(59.7K)
Depreciation208.5K354.5K343.6K350.6K382.7K281.4K
Other Non Cash Items(4.2M)42.9K50.5K39.6K84.1K88.3K
Capital Expenditures135.2K342.4K76.0K203.3K552.9K580.5K
Net Income(1.3M)2.1M1.3M1.6M2.2M2.3M
End Period Cash Flow6.5M8.9M4.5M3.8M2.3M3.0M
Change To Inventory(867.7K)196.8K43.1K245.5K(39.0K)(37.1K)
Change To Netincome(2.8M)291.5K577.7K440.9K396.8K416.7K
Investments(135.2K)(342.4K)(76.0K)(203.3K)(552.9K)(525.2K)

BioRem Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioRem's current stock value. Our valuation model uses many indicators to compare BioRem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioRem competition to find correlations between indicators driving BioRem's intrinsic value. More Info.
BioRem Inc is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about  0.24  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BioRem Inc is roughly  4.08 . At this time, BioRem's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioRem's earnings, one of the primary drivers of an investment's value.

BioRem Inc Systematic Risk

BioRem's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioRem volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on BioRem Inc correlated with the market. If Beta is less than 0 BioRem generally moves in the opposite direction as compared to the market. If BioRem Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioRem Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioRem is generally in the same direction as the market. If Beta > 1 BioRem moves generally in the same direction as, but more than the movement of the benchmark.

BioRem Inc Total Assets Over Time

Today, most investors in BioRem Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BioRem's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of BioRem growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.19

At this time, BioRem's Price Earnings To Growth Ratio is fairly stable compared to the past year.

BioRem November 30, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of BioRem help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioRem Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioRem Inc based on widely used predictive technical indicators. In general, we focus on analyzing BioRem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioRem's daily price indicators and compare them against related drivers.

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.